Line 194: | Line 194: | ||
<div class="wrapper"> | <div class="wrapper"> | ||
<nav> | <nav> | ||
− | <img id="ASIJ" src=" | + | <img id="ASIJ" src="https://static.igem.org/mediawiki/2018/6/6b/T--ASIJ_Tokyo--SchoolLogo.png"> |
<ul> | <ul> | ||
<li><a class="active" href="https://2018.igem.org/ASIJ_Tokyo">Home</a></li> | <li><a class="active" href="https://2018.igem.org/ASIJ_Tokyo">Home</a></li> | ||
Line 226: | Line 226: | ||
<tr> | <tr> | ||
<td rowspan="2"> | <td rowspan="2"> | ||
− | <img id="liver" src=" | + | <img id="liver" src="https://static.igem.org/mediawiki/2018/f/f6/T--ASIJ_Tokyo--Liver.png" height="375px" alt="liver"> |
<td id="title"><p >A1-AT<br>de<span style="color:rgb(182, 9, 23)">LIVER</span>y </p></td> | <td id="title"><p >A1-AT<br>de<span style="color:rgb(182, 9, 23)">LIVER</span>y </p></td> | ||
</td> | </td> |
Revision as of 11:20, 12 October 2018
A1-AT |
|
Using Stem Cell and CRISPR Technology to Combat Alpha-1 Antitrypsin Deficiency |